BIOMAT Database Logo BIOMAT Database Logo

Clinical trials to evaluate cost-effectiveness. 1989

B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
Department of Radiology, University of Arizona College of Medicine, Tucson 85724-0001.

UI MeSH Term Description Entries
D009316 National Institutes of Health (U.S.) An operating division of the US Department of Health and Human Services. It is concerned with the overall planning, promoting, and administering of programs pertaining to health and medical research. United States National Institutes of Health,National Institutes of Health
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D012109 Research Support as Topic Work about financial support of research activities. Grants and Subsidies, Research,Subsidies, Research,Research Subsidies,Research Subsidy
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D006077 Government Agencies Administrative units of government responsible for policy making and management of governmental activities. Agencies, Government,Agency, Government,Government Agency
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D014487 Centers for Medicare and Medicaid Services, U.S. A component of the Department of Health and Human Services to oversee and direct the Medicare and Medicaid programs and related Federal medical care quality control staffs. Name was changed effective June 14, 2001. Centers for Medicare and Medicaid Services,United States Centers for Medicare and Medicaid Services,United States Health Care Financing Administration,Centers for Medicare and Medicaid Services (U.S.),HCFA,Health Care Financing Administration,Health Care Financing Administration (U.S.),Health Care Financing Administration, U.S.

Related Publications

B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
Cost/effectiveness considerations in clinical trials.
January 1980, Triangle; the Sandoz journal of medical science,
B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
How to evaluate drugs. Cost-effectiveness analysis.
July 1990, JAMA,
B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
Cost-effectiveness analysis for multinational clinical trials.
July 2005, Statistics in medicine,
B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
Cost-effectiveness analyses alongside randomised clinical trials.
January 2006, Clinical trials (London, England),
B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
Cost-effectiveness and lung cancer clinical trials.
October 2003, Cancer,
B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
How to evaluate clinical trials.
January 1990, The National medical journal of India,
B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
Clinical and cost-effectiveness of insulin degludec: from clinical trials to clinical practice.
May 2015, Journal of comparative effectiveness research,
B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
Cost-effectiveness of strategies to evaluate postmenopausal bleeding.
June 1993, Obstetrics and gynecology,
B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
Clinical trials of cost effectiveness in technology evaluation.
June 2000, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR),
B J Hillman, and J P Kahan, and C R Neu, and G T Hammons
Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data.
January 2007, Clinical trials (London, England),
Copied contents to your clipboard!